LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹8.11 Cr | ₹7.67 Cr | ₹0.70 Cr | ₹-1.88 Cr | ₹-4.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹8.11 Cr |
| Mar2025 | ₹7.67 Cr |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹-1.88 Cr |
| Mar2022 | ₹-4.50 Cr |
How is Net Cash Inflow / Outflow of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.11 Cr | 5.80 | |
| Mar2025 | ₹7.67 Cr | 1,003.17 | |
| Mar2024 | ₹0.70 Cr | Positive | |
| Mar2023 | ₹-1.88 Cr | Negative | |
| Mar2022 | ₹-4.50 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,117.0 Cr | -1.8% | -12.8% | 5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1.8% |
-12.8% |
5.3% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses